The VHL-HIF Signaling in Renal Cell Carcinoma: Promises and Pitfalls

doi 10.5772/27009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

InTech

Related search

A HIF-Regulated VHL-PTP1B-Src Signaling Axis Identifies a Therapeutic Target in Renal Cell Carcinoma

Science Translational Medicine
Medicine
2011English

Inactivation of the PBRM1 Tumor Suppressor Gene Amplifies the HIF-response in VHL−/−clear Cell Renal Carcinoma

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2017English

Insights Into Epigenetic Remodeling in VHL-Deficient Clear Cell Renal Cell Carcinoma

Cancer Discovery
Oncology
2017English

The Role of VHL in Clear-Cell Renal Cell Carcinoma and Its Relation to Targeted Therapy

Kidney International
Nephrology
2009English

VHL Deletion in Renal Epithelia Causes HIF-1α-dependent, HIF-2α-independent Angiogenesis and Constitutive Diuresis

Oncotarget
Oncology
2016English

VHL Loss Predicts Response to Aurora Kinase a Inhibitor in Renal Cell Carcinoma Cells

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Personalized Medicine: Promises and Pitfalls

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2017English

MYC Activation Cooperates With VHL and Ink4a/Arf Loss to Induce Clear Cell Renal Cell Carcinoma

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

CRISPR-Mediated VHL Knockout Generates an Improved Model for Metastatic Renal Cell Carcinoma

Scientific Reports
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy